Literature DB >> 11326002

Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.

A Holguín1, B Aracil, A Alvarez, C Barros, V Soriano.   

Abstract

Plasma specimens collected in 1999 from 32 human immunodeficiency virus type 1 (HIV-1)-infected foreigners living in Madrid, Spain, were examined for the presence of non-B subtypes. Furthermore, plasma viremia was quantified using two different AMPLICOR HIV-1 MONITOR tests, version 1.0 and the new upgraded and automated version 1.5 (COBAS). Most patients came from Africa, where they most likely had acquired HIV-1 infection through sexual contact. HIV-1 genetic subtyping was based on the phylogenetic analysis of the protease gene. Twenty-two subtype B, six subtype G, two subtype C, one subtype A, and one D subtype infection were found. Overall, non-B subtypes represented 31.25% of the study population. Irrespective of the HIV-1 variant, viral load values above the detection limit (200 HIV RNA copies/ml) increased from 56.2 to 71.9% for results obtained using MONITOR version 1.0 and COBAS, respectively. Moreover, significant differences in viral load values (>0.5 logs) were recognized in up to 37.5% of samples. In summary, COBAS seemed to be more reliable for testing plasma viral load in HIV-infected immigrants living in Spain, one third of whom carried non-B subtypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326002      PMCID: PMC88037          DOI: 10.1128/JCM.39.5.1850-1854.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K.

Authors:  K Triques; A Bourgeois; N Vidal; E Mpoudi-Ngole; C Mulanga-Kabeya; N Nzilambi; N Torimiro; E Saman; E Delaporte; M Peeters
Journal:  AIDS Res Hum Retroviruses       Date:  2000-01-20       Impact factor: 2.205

2.  Human immunodeficiency viruses type 1 subtypes circulating in Sspain.

Authors:  A Holguín; B Rodés; U Dietrich; V Soriano
Journal:  J Med Virol       Date:  1999-10       Impact factor: 2.327

3.  Recombinant human immunodeficiency viruses type 1 circulating in Spain.

Authors:  A Holguín; B Rodés; V Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-20       Impact factor: 2.205

4.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

5.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

Authors:  J M Coffin
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

6.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

8.  Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.

Authors:  H Sato; Y Tomita; K Shibamura; T Shiino; T Miyakuni; Y Takebe
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network.

Authors:  E Couturier; F Damond; P Roques; H Fleury; F Barin; J B Brunet; F Brun-Vézinet; F Simon
Journal:  AIDS       Date:  2000-02-18       Impact factor: 4.177

10.  HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.

Authors:  I Loussert-Ajaka; T D Ly; M L Chaix; D Ingrand; S Saragosti; A M Couroucé; F Brun-Vézinet; F Simon
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

View more
  7 in total

1.  Prevalence of different HIV-1 subtypes in an urban clinic in Madrid.

Authors:  J C Martín; A Holguín; V Soriano
Journal:  Sex Transm Infect       Date:  2002-02       Impact factor: 3.519

2.  Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.

Authors:  Vincent Foulongne; Brigitte Montes; Marie-Noelle Didelot-Rousseau; Michel Segondy
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.

Authors:  Nicole H Tobin; Gerald H Learn; Sarah E Holte; Yang Wang; Ann J Melvin; Jennifer L McKernan; Diane M Pawluk; Kathleen M Mohan; Paul F Lewis; James I Mullins; Lisa M Frenkel
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Entirely automated quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma by using the ultrasensitive COBAS AMPLICOR HIV-1 monitor test and RNA purification on the MagNA pure LC instrument.

Authors:  Gabriele Hölzl; Markus Stöcher; Victoria Leb; Herbert Stekel; Jörg Berg
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.

Authors:  Cheryl Jennings; Brian Harty; Suzanne Granger; Carrie Wager; John A Crump; Susan A Fiscus; James W Bremer
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

6.  Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.

Authors:  Africa Holguín; Marisa López; Mar Molinero; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

7.  Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNA.

Authors:  Donald J Brambilla; Cheryl Jennings; Ralph Morack; Suzanne Granger; James W Bremer
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.